Method and Apparatus for Manufacturing Graphene
This technology offers a novel, low-cost method for producing high-purity graphene via electrochemical exfoliation. By placing non-contact graphite in a su…
Graphene Production: ~30% Cost Cut, Simplified Process for High-Purity Material
~$200K/year estimated manufacturing cost reduction per facility (est.)
Lithium-Ion Secondary Battery Cathode, Lithium-Ion Secondary Battery, and Method for Man…
This technology introduces a novel lithium-ion battery cathode design utilizing two distinct lengths of carbon nanomaterials. By optimizing their ratio and…
Dual Carbon Structure Boosts LiB Life by 20%, Output by 15%
~$1.5M/year estimated battery replacement cost reduction per facility (est.)
V-ATPase Activity Inhibitor, Antibacterial Agent, Pharmaceutical, Antibacterial Method, …
This technology provides a novel antibacterial agent that selectively inhibits bacterial Na+-transporting V-ATPase, suppressing pathogen growth. It address…
Novel V-ATPase Inhibitor: Cuts Drug Discovery Time by 20%, ~$1M Annual Savings
~$1.0M/year estimated healthcare cost reduction and 20% development time reduction (est.)
Solid Electrolyte, Electrolyte Layer, and Battery
This technology introduces a novel hexagonal perovskite-related solid electrolyte, engineered to deliver high electrical conductivity even in low-temperatu…
Next-Gen Solid-State Batteries: 5% Energy Gain, 10% Longer Life at Low Temps
~$1.5M/year estimated operational cost reduction and performance improvement per facility (est.)
Cross-linked Polymer Compound and Manufacturing Method, Absorbent Articles, and Waste Tr…
This technology introduces a novel cross-linked polymer that maintains high absorbency while being easily decomposable after use. It addresses critical env…
Waste Reduction by up to 80%, Maintaining High Absorbency for Sustainable Products
~$2.5M/year estimated waste treatment cost reduction per facility (est.)
Leukemia Cell Proliferation Inhibitor Containing FKI-7550A and FKI-7550B Substances as A…
This technology introduces FKI-7550A/B, novel compounds derived from a Fusarium fungal strain, as potent inhibitors of leukemia cell proliferation. It offe…
New Leukemia Treatment: FKI-7550 Offers Novel Mechanism, ~3x Faster Development
~$33.5M/year estimated new treatment market creation potential (est.)
Method for Manufacturing Boron Nitride
This technology precisely controls boron nitride particle shape and size, producing large columnar particles instead of traditional flakes. This enhances t…
Precision BN Particles Boost Thermal Conductivity 1.5x, Improve Filling
~$200K/year estimated cost reduction per facility (est.)
Medical Oxygen Mask
This innovative oxygen mask features a sliding oral access door and specialized nasal air inlets, allowing patients to eat, drink, and converse without rem…
Enhance Patient QOL by 3x, Cut Medical Workflow by 20% with New Oxygen Mask
~$100K/year estimated medical cost reduction per facility (est.)
Gel Composition and Method for Manufacturing Gel Composition
This technology enables the simple, cost-effective production of stable 3D carbon nanotube (CNT) gels. Utilizing a unique dispersant, it creates uniform CN…
Achieve 25% Cost Savings with Simplified 3D CNT Gel Production
~$200K/year estimated cost reduction per facility (est.)
Composition, Cured Film, Laminate, Vessel, Underwater Structure, Medical Device, and Mic…
This technology offers a novel polymer composition that forms a durable coating, providing long-term antifouling performance in harsh saltwater environment…
Extend maintenance cycles by ~20%, cut fuel costs 5% with new antifouling coating
~$1M/year estimated operational cost reduction per facility (est.)
Pre-treatment Method for Organic Waste, Organic Waste Treatment Method, and Pre-treatmen…
This bio-pre-treatment technology leverages the black soldier fly larval gut microbiome to efficiently decompose odor-causing organic waste. It significant…
Organic Waste: 90% Odor Reduction, Circular Bio-Processing with BSF Gut Microbes
~$100K/year estimated processing cost reduction per facility (est.)
Diagnostic Agent for Measuring Organic Anion Transporter Function
This technology provides a diagnostic agent for easily and accurately assessing Organic Anion Transporter Polypeptide (OATP) function using a radiolabeled …
Personalized Medicine Accelerated: OATP Test Cuts Drug Development by ~10%
~$1.0M/year estimated medical cost reduction per facility (est.).
Compound, Surface Treatment Agent, and Surface Treatment Method
This patent introduces a novel compound for efficiently applying multiple functional groups to material surfaces in a single step. It eliminates complex pr…
Streamlined Surface Treatment: 50% Process Cut, Multi-functional Materials
~$1.0M/year estimated manufacturing cost reduction per facility (est.)
Viral Infection Inhibitor and Method for Inhibiting Viral Infection in Cells
This technology utilizes a novel compound to physically prevent viral attachment to host cells, offering a broad-spectrum defense against various viruses. …
Block ~33% of Viral Infections: New Cell Protection Strategy
~$1.0M/year estimated economic loss reduction per facility (est.)
Agent for Preventing or Treating Tubulointerstitial Disorder
This technology offers an innovative screening method for tubulointerstitial disorder, a key factor in chronic kidney disease progression. By targeting the…
Kidney Drug Discovery: Accelerate by 2 Years, Boost Efficiency 1.5x
~$13.5M/year estimated economic impact from 2-year drug development acceleration (est.).
Modified Human Interleukin-4 Receptor Polypeptide and M2 Macrophage Differentiation Indu…
This patent introduces a modified human IL-4 receptor polypeptide that efficiently induces M2 macrophage differentiation. Unlike conventional methods, it o…
M2 Macrophage Induction: Accelerate Drug Development by ~30%
~$13M/year estimated R&D cost reduction per development program (AI est.)
Article, Method for Manufacturing Article, Composite, and Method for Manufacturing Compo…
This technology utilizes a modified polylactic acid (PLA) surface to enable cells to autonomously form complex 3D structures, mimicking biological tissues.…
3D Cell Sheets: Precision Tissue Recreation, Accelerating R&D by 5×
~$800K/year estimated cost reduction and efficiency per facility (est.)
Photocatalyst, Photoelectrode Using the Same, and Methods for Manufacturing These
This technology enhances photocatalyst surfaces with phosphate groups, dramatically boosting hydrogen ion supply for water splitting. It significantly impr…
1.5x Hydrogen Production Boost for Green Energy & Decarbonization
~$1.5M/year estimated hydrogen cost reduction for fuel cells per facility (est.)
Tea Variety Identification Method, Polynucleotide, Microsatellite Marker, and Primer Set
This technology uses specific DNA markers (microsatellites) for highly accurate and rapid identification of tea varieties. It helps combat food fraud, ensu…
Tea Variety ID: 99% Accuracy, Boosts Brand Value by 2x, Cuts Costs 30%
~$0.7M/year estimated brand value enhancement and loss avoidance per facility (est.)
Polyoxazoline-Conjugated Albumin, Artificial Plasma Expander, and Hemorrhagic Shock Resu…
This technology introduces a novel polyoxazoline-conjugated albumin, designed as a highly biocompatible and stable artificial plasma expander. It addresses…
Artificial Plasma: ~20% Lower Costs, Stable Supply for Emergencies
~$100M/year estimated healthcare cost reduction per country (est.).
Composition, Members, and Protective Gear
This technology combines inorganic oxide particles with a specialized ionic liquid to create a shear-thickening fluid. It remains flexible in normal use bu…
Stable Shear-Thickening Fluid Doubles Impact Protection Performance
~$350K/year estimated accident-related cost reduction per facility (est.)
Tin Sulfide Crystal Colloidal Particles and Their Applications
This technology introduces novel tin sulfide colloidal particles, precisely controlled to under 9nm, leveraging quantum confinement for tunable light absor…
9nm Quantum Dots: Boost Solar Efficiency by 20%, Cut Material Costs
~$1.0M/year estimated manufacturing cost reduction per facility, with a 5% increase in power generat…
Skin Patch with Non-Adhesive Zone for Medical Device Fixation and Pressure Prevention
This multi-layered skin patch features distinct non-adhesive and adhesive zones, designed to securely fix medical devices like catheters while preventing p…
Zero Pressure Medical Patch: 2x Operability, ~30% Skin Trouble Reduction
~$200K/year estimated cost savings per facility (est.)
MRP3-Targeted Gene-Modified T-Cells
This gene-modified T-cell therapy targets advanced liver cancer by introducing a T-cell receptor (TCR) specific to MRP3-HLA-A24 complexes into patient-deri…
MRP3-Targeted T-Cell Therapy: 3x Faster Efficacy for Advanced Liver Cancer
~$1.5M/year estimated medical cost reduction and QOL improvement (est.).